Supplements

• Addressing the impact of the RSV vaccine

  

  • September 2024, Cleveland Clinic Journal of Medicine: 91 (9 suppl 1)

• Complement-mediated kidney disease: C3 glomerulopathy and IgA nephropathy

  • June 2023, Cleveland Clinic Journal of Medicine: 90 (6 suppl 1)

• Cardiovascular Disease: From challenges to clearer pathways

  • May 2020, Cleveland Clinic Journal of Medicine: 87 (5 suppl 1)

• Obstructive sleep apnea: A wake-up call for better outcomes

  • September 2019, Cleveland Clinic Journal of Medicine: 86 (9 suppl 1)

• COPD in primary care: Key considerations for optimized management

  • February 2018, Cleveland Clinic Journal of Medicine: 85 (2 suppl 1)

• Biostatistics and epidemiology lecture series, part 1

  • September 2017, Cleveland Clinic Journal of Medicine: 84 (9 suppl 2)

• Diabetes and obesity: Managing dual epidemics

  • July 2017, Cleveland Clinic Journal of Medicine: 84 (7 suppl 1)

• Selected presentations from Sones/Favaloro Scientific Program

  • December 2017, Cleveland Clinic Journal of Medicine: 84 (12 suppl 4)

• Challenges and advances in cardiovascular disease

  • December 2017, Cleveland Clinic Journal of Medicine: 84 (12 suppl 3)

• Cardiovascular disease: Innovations in devices and techniques

  • November 2016, Cleveland Clinic Journal of Medicine: 83 (11 suppl 2)

Previous

Next

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8